Orion - Company Announcement

Orion Corporation's publication schedules for financial reporting in 2016

ORION CORPORATION      STOCK EXCHANGE RELEASE 28 JULY 2015 at 9.45 a.m.
EEST

Orion Corporation's publication schedules for financial reporting in 2016


Orion Corporation will publish its Financial Statement Release 2015 on Tuesday,
2 February 2016.


The publication dates of the Interim Reports in 2016 are as follows:


Interim Report January-March 2016                    Wednesday, 27 April 2016
Interim Report January-June 2016                      Tuesday, 19 July 2016
Interim Report January-September 2016             Tuesday, 25 October 2016

The Financial Statements and the report of the Board of Directors 2015 will be
published on the Company's website at the latest in week 9/2016.


The Annual General Meeting is planned to be held on Tuesday, 22 March 2016 in
Helsinki.


Orion's financial reports and related presentation material are available on the
Group's website at http://www.orion.fi/investors promptly after the publishing.
The website also provides a possibility to register on Orion's mailing lists for
releases.

Orion Corporation

Timo Lappalainen    Olli Huotari
President and CEO   SVP, Corporate Functions


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02101 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. The core therapy areas of Orion's pharmaceutical R&D are
central nervous system (CNS) disorders, oncology and respiratory for which Orion
developes inhaled Easyhaler® pulmonary drugs.
Orion's net sales in 2014 amounted to EUR 1,015 million and the Company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ Helsinki.


[HUG#1941634]